JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M002040200 on April 11, 2000

J. Biol. Chem., Vol. 275, Issue 30, 23113-23119, July 28, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/30/23113    most recent
M002040200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arthur, T. M.
Right arrow Articles by Burgess, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arthur, T. M.
Right arrow Articles by Burgess, R. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Mutational Analysis of beta '260-309, a sigma 70 Binding Site Located on Escherichia coli Core RNA Polymerase*

Terrance M. ArthurDagger §, Larry C. AnthonyDagger §, and Richard R. BurgessDagger

From the Dagger  McArdle Laboratory for Cancer Research and the § Department of Bacteriology, University of Wisconsin, Madison, Wisconsin 53706

Received for publication, March 10, 2000, and in revised form, April 9, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In eubacteria, the sigma  subunit binds to the core RNA polymerase and directs transcription initiation from any of its cognate set of promoters. Previously, our laboratory defined a region of the beta ' subunit that interacts with sigma 70 in vitro. This region of beta ' contained heptad repeat motifs indicative of coiled coils. In this work, we used 10 single point mutations of the predicted coiled coils, located within residues 260-309 of beta ', to look at disruption of the sigma 70-core interaction. Several of the mutants were defective for binding sigma 70 in vitro. Of these mutants, three (R275Q, E295K, and A302D) caused cells to be inviable in an in vivo assay in which the mutant beta ' is the sole source of beta ' subunit for the cell. All of the mutants were able to assemble into the core enzyme; however, R275Q, E295K, A302D were defective for Esigma 70 holoenzyme formation. Several of the mutants were also defective for holoenzyme assembly with various minor sigma  factors. In the recently published crystal structure of Thermus aquaticus core RNA polymerase (Zhang, G., Campbell, E. A., Minakhin, L., Richter, C., Severinov, K., and Darst, S. A. (1999) Cell 98, 811-824), the region homologous to beta '260-309 of Escherichia coli forms a coiled coil. Modeling of our mutations onto that coiled coil places the most defective mutations on one face of the coiled coil.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The DNA-dependent RNA polymerase (RNAP)1 is a multisubunit enzyme that plays a central role in eubacterial gene regulation and expression. This enzyme has two functional forms: core and holoenzyme. Transcription elongation and termination are performed by the core enzyme with alpha :2,beta :1,beta ':1 stoichiometry (1). Core RNAP binds one of a variety of sigma  subunit species at a given time to form a specific holoenzyme (2). The holoenzyme performs the tasks of promoter recognition and transcription initiation. Each sigma  subunit directs its cognate holoenzyme to start transcription from only those promoters containing DNA sequences specifically recognized by that sigma  factor (2-4).

Understanding the molecular basis of sigma  binding to core RNAP will aid in the analysis of several questions involving how multiple sigma  species come to sequester core and turn on subsequent genes. It has been hypothesized that all of the sigma  species bind to the same site/sites on the core enzyme (1, 6, 7). Studies to identify the core binding site on sigma  have resulted in the positive identification of a single binding site located on sigma 70 overlapping conserved region 2.1 (5, 8). A single point mutation in the homologous region of Bacillus subtilis sigma E prevented binding to core (9). More recent genetic and biochemical studies suggest that region 2.1 may be only one of multiple contact sites that sigma  uses in binding to the core enzyme (6, 10, 11).

Information about sites on core that bind sigma  has come in most part from biochemical assays. Protein footprinting studies of the core enzymes susceptibility to hydroxy radical cleavage upon binding a modified sigma  factor containing the cleavage catalyst have revealed that there are three regions on the core, one located on beta ' and two on beta , that are in close proximity to sigma  (12). One of the beta  regions was identified earlier as being near the sigma 70 binding region. It was noticed that this site, in the core enzyme complex, was cleaved by trypsin, whereas formation of Esigma 70 prevented trypsin cleavage at this site (13). Previous in vitro work from our laboratory identified a strong binding site for sigma 70 on the beta ' subunit (14). This site was mapped to within residues 260-309 of beta '.

The predicted secondary structure (15) of beta '260-309 has two alpha  helices joined by a random coil. Another structural analysis program indicates that these two helices are amphipathic and have the potential for coiled coil formation (16). The coiled coil motif is based on a heptad repeat of residues designated a-g (17, 18) (Fig. 1B). The a and d positions are hydrophobic, whereas the other positions are usually charged or polar. Burial of the a and d hydrophobic residues during coiled coil formation provides a large amount of the binding energy. Specificity in binding comes from the e and g positions, which can form ionic interactions or salt bridges.

We have undertaken a mutational analysis of this region to confirm that our in vitro binding results were relevant to in vivo binding and function. This work presents the analysis of 10 point mutations, most of which are change-of-charge mutations at the e and g residues, in the beta '260-309 predicted coiled coil. Three of the mutations (R275Q, E295K, and A302D) were nonfunctional in binding sigma 70 in all of the assays in which they were tested but still able to assemble into the core enzyme. We also report on mutations that were nonfunctional in some of our assays but functional in others, indicating that binding of other sites may compensate for loss of binding at the beta '260-309 site. We use this analysis to demonstrate that the binding site identified previously by in vitro methods is important in vivo and that mutations in this region can greatly diminish core binding of sigma 70 and other minor sigma s. In the recently solved crystal structure for the core RNAP of Thermus aquaticus, the region homologous to Escherichia coli beta '260-309 was determined to form a "coiled coil-like" structure (19) consistent with our predictions. Modeling of our mutations onto the T. aquaticus structure places all of the nonfunctional mutations on the same face of the beta ' coiled coil.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Construction of Plasmids-- Plasmid characteristics are described in Table I. Plasmids pTA577 and 600-620 were made from the base plasmid pRL663 (20). Single HinDIII and BamHI restriction sites, at bases 674 and 952 of rpoC, respectively, were inserted into the rpoC gene of pRL663 via silent mutagenesis to create pTA577. pTA561 was created in the same manner as pTA577 except that pRL308 (22) was the starting plasmid. The HinDIII and BamHI restriction sites were used to insert polymerase chain reaction-generated DNA fragments containing the various mutations to generate pTA600-609. For pTA620, which contains a truncated rpoC fragment coding for beta ' residues 1-319, pRL663 was cut with Xba-HinDIII for insertion of a polymerase chain reaction-generated rpoC truncation. The sigma 70 binding site was previously mapped to residues 260-309 of beta '; however, we engineered some of the constructs for this work to extend to residue 319. This was done to incorporate the BamHI site mentioned previously. Therefore, the various mutations could be moved into the new plasmid to create pTA610-619. We have not seen any difference in behavior of the fragments ending at residue 309 as opposed to those ending at residue 319. All sequences generated via polymerase chain reaction were sequenced to ensure that spurious mutations had not been incorporated.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Plasmid list and characteristics

Expression and Purification of sigma 70-- The cells were grown to an A600 of 0.6-0.8 in 1-liter cultures at 37 °C in LB medium with 100 µg/ml ampicillin. Isopropyl-beta -D-thiogalactopyranoside was then added to a concentration of 1 mM. Three hours after induction, the cells were harvested by centrifugation at 8,000 × g for 15 min and frozen at -20 °C.

The cell pellet from a 1-liter culture was thawed and resuspended in 10 ml of lysis buffer (40 mM Tris, pH 7.9, 0.3 M KCl, 10 mM EDTA, and 0.1 mM phenylmethylsulfonyl fluoride), and lysozyme was added to 0.1 mg/ml. The cells were incubated on ice for 15 min and then sonicated in three 60-s bursts. The recombinant protein in the form of inclusion bodies was separated from the soluble lysate by centrifugation at 27,000 × g for 15 min. The inclusion body pellet was resuspended by sonication in 10 ml of lysis buffer + 2% (w/v) sodium deoxycholate. The mixture was centrifuged at 27,000 × g for 15 min, and the supernatant was discarded. The deoxycholate-washed inclusion bodies were resuspended in 10 ml of deionized water and centrifuged at 27,000 × g for 15 min. The water wash was repeated, and the inclusion bodies were aliquoted into 1-mg pellets and frozen at -20 °C until use.

sigma 70 inclusion bodies (10 mg) were solubilized, refolded, and purified according to a variation of the procedure of Gribskov and Burgess (21). The inclusion bodies were solubilized by resuspension in 10 ml of 6 M guanidine-HCl. The proteins were allowed to refold by diluting the denaturant 64-fold with Buffer A (50 mM Tris, pH 7.9, 0.5 mM EDTA, and 5% (v/v) glycerol) in 2-fold steps over 2 h. One gram of resin (DEAE-cellulose, Whatman) was added and mixed with slow stirring for 24 h at 4 °C. The resin was then collected in a 10-ml column and washed, and the protein was eluted with a gradient from 0.1 to 1.0 M NaCl in Buffer A. The sigma 70 fractions were pooled, dialyzed overnight against 1 liter of storage buffer (50 mM Tris, pH 7.9, 0.5 mM EDTA, 0.1 M NaCl, 0.1 mM dithiothreitol, and 50% (v/v) glycerol), and stored at -20 °C.

Quantitative Western Blotting-- Protein samples to be quantitated were subjected to SDS-polyacrylamide gel electrophoresis. The proteins were electrophoretically transferred out of the gel onto 0.05-µm nitrocellulose. The blot was blocked in Blotto (10 mM Tris, pH 7.4, 150 mM NaCl, 0.1% (v/v) Tween 20, and 3% (w/v) nonfat dry milk) and probed with monoclonal antibodies. The signal was generated using the ECL Plus system (Amersham Pharmacia Biotech) and detected on a Storm PhosphorImager (Molecular Dynamics). The signal was quantitated using ImageQuant software (Molecular Dynamics).

Far Western Blotting-- Cells containing truncated beta ' expression plasmids pTA610-620 were grown to A600 = 0.6-0.8 and induced with 1 mM isopropyl-beta -D-thiogalactopyranoside. The cells were grown for an additional 30 min. A 200-µl sample was removed and sonicated three times for 30 s each. 20 µl of glycerol and 20 µl of SDS sample buffer were added and heated for 2 min at 95 °C, and the sample was then stored at -20 °C until use. The lysates were separated by SDS-polyacrylamide gel electrophoresis. The proteins were electrophoretically transferred onto 0.05-µm nitrocellulose. The nitrocellulose was blocked by incubating in HYB buffer (20 mM Hepes, pH 7.2, 200 mM KCl, 2 mM MgCl2, 0.1 µM ZnCl2, 1 mM dithiothreitol, 0.5% (v/v) Tween 20, 1% (w/v) nonfat dry milk) for 16 h at 4 °C. A chimeric sigma 70 was created by fusing a heart muscle kinase recognition sequence to the N terminus of sigma 70 to facilitate radiolabeling of sigma 70. Labeling of sigma 70 was done in a 100-µl reaction volume. 50 µl of 2× kinase buffer (40 mM Tris, pH 7.4, 200 mM NaCl, 24 mM MgCl2, 2 mM dithiothreitol) was added to 50 µg of heart muscle kinase sigma 70 protein. 240 units of cAMP-dependent kinase catalytic subunit (Promega) was added and the total volume was brought to 99 µl with deionized water. One microliter of [gamma -32P]ATP (0.15 mCi/µl) was added. The mixture was incubated at room temperature for 30 min. The reaction mixture was then loaded onto a Biospin-P6 column (Bio-Rad) preequilibrated with 1× kinase buffer and centrifuged at 1100 × g for 4 min. The flow-through was collected and stored at -20 °C.

The blocked nitrocellulose was incubated in 10 ml of HYB buffer with 4 × 105 cpm/ml 32P-labeled sigma 70 for 3 h at room temperature. The blot was washed three times with 10 ml of HYB buffer for 3 min each. The blot was dried, and the signal was visualized with a PhosphorImager and quantitated with ImageQuant software (Molecular Dynamics).

Growth Assessment-- Plasmids pTA577 and 600-609 (0.1 µg) were transformed into strain RL602 (22, 23). After heat shock and incubation on ice, 300 µl of LB was added to the 50-µl cell mixture. 10 µl of the transformation reaction was spotted onto LB plates plus ampicillin (100 µg/ml) and incubated at 30 °C. Another 10 µl was spotted onto identical plates and incubated at 42 °C. The plates were incubated for 24-48 h and assessed for growth.

Purification of Core/Holo Complexes-- 1-liter flasks containing 200 ml of LB with ampicillin (100 µg/ml) and isopropyl-beta -D-thiogalactopyranoside (0.15 mM) were inoculated with 200 µl from overnight cultures of cells containing plasmids pTA561, 577, and 600-609. The cultures were grown at 37 °C with shaking until the A600 reached 0.4 for log phase assays and 2 h longer (A600 ~ 2.0) for the early stationary phase assays. The cells were harvested by centrifugation at 6,000 × g for 10 min and stored at -20 °C until use. The cell pellets were resuspended in 5 ml of TE (10 mM Tris, pH 7.9, and 0.1 mM EDTA) plus 0.15 M NaCl and lysozyme (0.1 mg/ml) and then incubated on ice for 15 min. The cells were sonicated three times for 30 s each and centrifuged for 25 min at 27,000 × g to remove the insoluble material. The supernatant was loaded onto a 1.5-ml immunoaffinity column containing the polyol-responsive, anti-beta ' monoclonal antibody NT73 (24). The column was washed with 15 ml of TE plus 0.15 M NaCl followed by a second wash with 10 ml of TE plus 0.5 M NaCl. The protein was eluted from the column with 4 ml of TE plus 0.7 M NaCl and 30% propylene glycol. The eluted sample (4 ml) was diluted with 6 ml of buffer 66 (20 mM Tris, pH 7.9, 500 mM NaCl, 5 mM imidazole, 0.1% (v/v) Tween 20, and 10% (v/v) glycerol) and loaded (2×) onto 500 µl of Ni2+-NTA resin. The resin was washed twice with 5 ml of buffer 66 and eluted with 0.5 ml of buffer 66 plus 0.25 M imidazole. Samples from the elution fractions were assayed by Western blot as described above, using monoclonal antibodies to each subunit or sigma  factor. The secondary antibodies were horseradish peroxidase-labeled goat anti-mouse IgG antibodies and the signal was generated using the ECL Plus substrate system (Amersham Pharmacia Biotech) and detected using the STORM PhosphorImager and quantitated with ImageQuant software (Molecular Dynamics).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Mutational Design-- Structural prediction, using the Coils program (16), scored both of the predicted alpha -helices of beta '260-309 as having a high probability of forming coiled coils (Fig. 1A). To test this prediction, we constructed two beta ' mutants with proline residues inserted into either helix. These beta ' mutants were no longer predicted to form helices or coiled coils. When assayed for function in both the far Western and in vivo growth assays, both mutants were found to be nonfunctional (data not shown). We took this to indicate that the helical/coiled coil structure in this region was important for function. The solubility of these mutant proteins was not 100%, so we ceased using them because their loss of function could simply be due to gross folding defects. We decided to concentrate in most part on the e and g positions of the alpha -helices for the next phase of our analysis. The e and g residues of coiled coils often engage in interhelical interactions, such as the formation of ionic interactions or salt bridges (17, 18). Such interactions in this case could be intramolecular (between the two helices of beta '260-309), forming a coiled coil structure necessary for binding by the sigma  subunit (Fig. 1B). Alternatively, the e and g residues of beta '260-309 could be making intermolecular contacts with sigma  upon binding. Our efforts were directed toward making change-of-charge mutations at these residues of beta ' (Fig. 1B) and assaying their effects on binding. Two of the mutations described in this work do not involve e or g residues and were chosen for other reasons. Based on the findings that tyrosine and arginine residues are often located in "hot spots" of protein-protein interactions (26), we changed the tyrosine residue at position 269 to an alanine and arginine 297 to a serine. Previous studies in our laboratory found that insertion of a leucine at position 297 generated a beta ' subunit that was nonfunctional for binding sigma 70 (unpublished results). Therefore, we were interested to determine whether a less drastic mutation at this position would also affect sigma  binding.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 1.   The beta "260-309 region. A, schematic diagram of beta '260-309 interaction domain. The lettered boxes represent the conserved regions of the largest subunits of the eukaryal and prokaryal RNAP (45). The beta '260-309 interaction domain overlaps part of the beta ' subunit conserved region 66. Below the interaction domain are diagrams of the predicted alpha  helices and coiled coils. B, hypothetical helical wheel drawing of predicted beta '260-309 coiled coil. The two predicted helices are shown as interacting with one another to form an antiparallel coiled coil. Mutations are shown next to original residues along with the residue number. The N terminus is at amino acid Asn-266 on the right helix. The right helix is drawn as coming out of the page, whereas the left helix is drawn as going into the page and terminates at Asn-309.

Several of the Mutations in the beta '260-319 Region Disrupt Interaction with sigma 70 in a Far Western Assay-- Previously, we had used far Western blotting to map a sigma 70 binding site to the N-terminal region of the beta ' subunit (14). We again applied this procedure as an initial assay for functionality of our beta ' mutants. The mutations were cloned into a gene fragment coding for amino acids 1-319 of the beta ' subunit. Cells containing these genes were induced for a short period to give moderate levels of the beta ' fragment, comparable to other proteins in the extract. Samples were analyzed for binding sigma 70 by far Western analysis as described under "Experimental Procedures." The amount of sigma 70 probe bound by each beta '1-319 mutant fragment was compared with the amount bound by wt beta '1-319 fragment. Each signal was normalized to the amount of beta '1-319 contained in the supernatant as determined by Western blotting.

Five of the mutations (R275Q, R293Q, E295K, R297S, and A302D) were greatly reduced in their ability to bind sigma 70 (Fig. 2). The Q300E and N309D mutations had the opposite effect, binding more sigma 70 than wild type beta '1-319. Q300E exhibited an increase in relative binding of greater than 7-fold. There were no effects on binding seen with the N266D, Y269A, or K280E mutations.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 2.   Western and far Western blots of cell extracts containing wt or mutant beta '1-319. Cell extracts of the indicated beta ' mutants were separated by 8-16% Tris-glycine SDS-polyacrylamide gel electrophoresis, blotted to nitrocellulose, and probed with an anti-beta ' antibody (A) or 32P-labeled sigma 70 (B). C, relative binding of sigma 70 by wt and mutant beta ' fragments. The values for relative sigma 70 binding by wt versus mutant beta '1-319 fragments determined from far Western blotting analysis were normalized to the amount of beta '1-319 fragment loaded as determined by quantitative Western blot analysis (wt = 1.0). Error bars represent S.D. Results are the average of three different experiments.

Complementation with Mutant beta ' Subunits-- To assess the importance of the sigma 70 binding site in vivo, we assayed the ability of mutant beta ' subunits to function as the sole source of beta ' for the cell. Plasmids containing mutant or wild type, full-length beta ' were transformed into strain RL602 (22, 23). The chromosomal rpoC gene of RL602 has an amber mutation that prevents functional beta ' from being produced in the absence of a suppressor tRNA. RL602 also has a chromosomal, temperature-sensitive amber suppressor. At the permissive temperature (30 °C), the amber suppressor is active and allows chromosomal beta ' to be produced and the cell can grow. The amber suppressor is not active at the nonpermissive temperature (42 °C). Therefore, at 42 °C, chromosomal beta ' is not made, and the cell cannot grow without another source of beta '. If the plasmid-derived beta ' can complement the loss of beta ', then the cells will grow and form colonies on plates at the nonpermissive temperature. If the mutant beta ' cannot complement, there will be no growth on the plates at this temperature.

Three of the beta ' mutants that were defective for sigma  binding in the far Western assay (R275Q, E295K, and A302D) could not support growth at the nonpermissive temperature, indicating that these mutations were also caused defects in binding sigma  in vivo (Fig. 3). N266D, a mutation that had no detectable effect in the far Western assay, allowed some growth at the nonpermissive temperature but not enough to be considered wild type. In contrast, the R293Q and R297S mutations that did not bind sigma 70 in the far Western assay could support growth in vivo. Mutations Y269A, K280E, Q300E, and N309D had no detectable effects on growth. Expression levels for nonfunctional beta ' mutants were determined to be equivalent to that of plasmid-derived, wild type beta ' when grown at 37 °C (data not shown).


View larger version (58K):
[in this window]
[in a new window]
 
Fig. 3.   Growth with plasmid-derived wt or mutant beta ' as the sole source of beta ' subunit. Strain RL602 was transformed with plasmids encoding either wt or mutant full-length beta '. Transformed cells (10 µl) were then spotted onto duplicate plates, incubated at either 30 °C (permissive) or 42 °C (nonpermissive) for 24-48 h, and then assessed for growth.

Effects of beta ' Mutations on Core/Holoenzyme Assembly-- An alternate explanation for the inviability caused by some of the beta ' mutations would be that they are no longer able to be assembled into the core enzyme. To evaluate the potential assembly defects caused by the various mutations, we expressed His6-tagged, mutant beta ' subunits in cells that were also expressing wild type, chromosomal beta ' proteins. We used a Ni2+-NTA mediated pull-out assay to purify the mutant beta  subunits together with associated cell proteins. An immunoaffinity column was used to clean up the samples in order to reduce any nonspecific binding to the Ni2+-NTA column.

All of the mutant beta ' subunits tested retained the ability to assemble into the core enzyme demonstrated by the association of the alpha  and beta  subunits throughout the purification (Fig. 4, A and B). Again, mutations R275Q, E295K, and A302D caused defects in binding sigma 70 in both log and stationary phase samples (Fig. 4C). Also reduced in Esigma 70 formation were N266D in both log and stationary phase samples and R297S in log phase samples. Q300E again showed properties of binding sigma 70 better than wild type. Y269A, K280E, R293Q, and N309D had no detectable effect on Esigma 70 assembly. When a non-His6-tagged beta ' was expressed from the plasmid, there was no detectable nonspecific binding to the Ni2+-NTA column.


View larger version (52K):
[in this window]
[in a new window]
 
Fig. 4.   Assembly of core and/or holoenzyme. Cells grown with wt or mutant beta ' expression plasmids were harvested and subjected to purification to isolate the plasmid-derived, His6-tagged beta ' and any of its assembled complexes. Proteins from Ni2+-NTA-purified samples were separated via SDS-polyacrylamide gel electrophoresis and blotted to nitrocellulose. The blots were then probed with monoclonal antibodies against the indicated subunits. A, log phase samples. B, stationary phase samples. No His6, strain expressing plasmid-derived, wt beta ' without a hexahistidine tag. C, quantitation of relative sigma 70 binding for the mutants versus wild type beta ', normalized to the amount of the alpha  subunit retained (wt = 1.0). Results are the average of three different experiments. Error bars represent standard deviation. D and E, log and stationary samples, respectively, probed for minor sigma  factors.

All of the sample eluates were also assayed for the presence of any minor sigma  species. The only minor sigma s of which the concentrations were sufficient for detection were sigma 32 in log phase and sigma 32 and sigma F in stationary phase samples. The results for these sigma s were essentially the same as for sigma 70 with the exception of mutants R297S and Q300E. In stationary phase samples from the Q300E mutant, the sigma 32 and sigma F levels are greatly reduced, whereas the sigma 70 levels are above those in the wt. The log phase samples for this mutant also contained a decreased amount of sigma 32 indicating a defect in Esigma 32 formation but not as severe as in stationary phase.

Molecular Modeling of beta ' Mutations-- Recently, Zhang et al. (19) published the crystal structure of T. aquaticus core RNAP. The beta '260-309 region of E. coli RNAP has a high degree of sequence conservation with its T. aquaticus homolog (Fig. 5A).2 This region of the T. aquaticus beta ' subunit forms a coiled coil-like structure. When the mutations studied here are modeled onto the T. aquaticus structure using the Rasmol program (25), those that are most defective in sigma  binding are grouped on one face of the coiled coil. Those that had defective phenotypes in some assays but not others are on the outer edges of this face. Mutations that had no detectable effects are clustered on the opposite face of the coiled coil, with the exception of N309D, which is located at the very C terminus of the coiled coil immediately next to the "rudder" (19) (Fig. 5, B and C).


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 5.   Modeling of mutations. A, protein sequence alignment of E. coli beta '260-309 and the homologous region from T. aquaticus. Shaded letters represent those not identical to E. coli. B and C, two views of mutations modeled onto the crystal structure of T. aquaticus core RNAP (19) using the Rasmol program (25). B, oriented looking down the center of the coiled coil, toward the polymerase. C, side view of the coiled coil. The mutations that were defective in all assays tested are colored green. Mutations that were defective in some assays, but not all, are colored cyan. Mutations that were always functional are colored purple. Rudder, colored maroon, is added to orient the structure (19).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Binding of various sigma  factors to the core polymerase is a major step in the process of global gene expression and regulation. It is not known whether this step is part of the regulation, via a competition for binding to a limited core population, or merely a straight-forward binding of free sigma s to an excess of core (27-30). If there is competition among populations of sigma  species for core binding, that competition may be influenced by binding specificity of the sigma s. In light of the high sequence conservation of most sigma  species, it has been thought that all sigma  factors bind to the same location(s) on the core enzyme (1). We had previously identified a binding site for sigma 70 in vitro (14). In this report, we verify the importance of this site for in vivo binding and function, identify important residues for sigma  binding, define a potential binding interface for the sigma -core interaction, and show that this binding site is involved in binding at least some of the minor sigma  factors.

Our mutational analysis was designed to look for loss of sigma 70 binding by targeting residues of the 260-309 region of the beta ' subunit that were identified as occupying e or g positions in the predicted coiled coil structure. Based on our results, we have divided the mutations into three groups: nonfunctional for sigma  binding in all assays tested, nonfunctional in some assays but not others, and functional in all assays tested. The first group contains the mutations R275Q, E295K, and A302D. These three mutations were nonfunctional for sigma 70 binding in vitro and in vivo, indicating that they play a very important role in binding sigma 70. Arginine 275 is located near the C terminus of the first of the two putative helices, whereas glutamate 295 and alanine 302 are in the middle and near the C terminus of the second helix, respectively. This confirms what we had found with our earlier mapping work that both predicted helices of beta '260-309 were involved in binding sigma 70. The mutations made at these residues were the only ones tested that could not support any detectable growth when the expression of the chromosomal beta ' subunit was turned off. This is significant in light of the fact that these mutant beta ' subunits, along with all those tested in this study, had no detectable defect in interactions with the alpha  and beta  subunits necessary to form the core enzyme. We conclude from these results that there are no gross folding defects that are responsible for the lack of sigma 70 binding.

It is possible that the local structure of these mutant proteins is disturbed. Sequence analysis of all 10 mutant subunits predicted no change in secondary structures as compared with the wild type protein (15, 31). The A302D change would be the most likely, though, of the three group 1 mutations to be disturbing the local structure. This introduces a bulky charged side chain in place of a single methyl group. Also, based on the crystal structure of the T. aquaticus core RNAP (19), the Ala-302 alpha  carbon is directed more toward the opposite helix of the coiled coil than are the side chains of Arg-275 or Glu-295, which are solvent-exposed. If R275Q and E295K are not affecting the local beta ' structure, then most likely, the negative sigma 70 binding properties are coming from steric hindrance, charge repulsion, or loss of a specific interaction with the sigma  subunit.

The group 2 mutants, N266D, R293Q, and R297S, are of particular interest because they seem to have some function depending on the assay in which they are analyzed. R293Q and R297S were not functional for in vitro sigma 70 binding in far Western assays but could support growth and were able to form core enzymes that were capable of binding sigma 70, although R297S does cause a decrease in the binding efficiency of the mutant core enzyme in log phase. The differences in the in vivo and in vitro assay results for these mutants can be explained in multiple ways. First, a positive result from the far Western assay requires that a beta ' fragment (amino acids 1-319) refold the secondary structure needed to bind sigma 70, whereas part of the protein is immobilized on a membrane. Therefore, mutations found to cause defects may be introducing in vitro folding deficiencies. Secondly, the in vivo assays are analyzing sigma  binding to the multisubunit core enzyme and not just an individual subunit or fragment. A great deal of evidence has been reported suggesting multiple binding sites on core RNAP for the sigma  factor (6, 10-12). Thus, loss of one of those sites may be compensated for by the remaining binding interactions. We believe that whereas R293Q and R297S mutations are disrupting sigma  binding to beta '260-309, they are not obstructing sigma 70 from making its other contacts on core polymerase.

In contrast to the previous group 2 mutations, N266D had no effect on sigma 70 binding to beta ' but caused reductions in Esigma 70 formation comparable to group 1 mutations and had a weak growth deficiency. Asn-266 is located at the base of the coiled coil and, when mutated, could change the local structure. This change may be causing a shift in the orientation of the coiled coil with respect to the rest of the core enzyme. This would not affect the binding of sigma 70 to the coiled coil but may disrupt other contacts normally made by sigma 70 with core.

The group 3 mutants, Y269A, K280E, Q300E, and N309D, were all fully functional, indicating that these residues are not making critical contacts with sigma 70. The Q300E change was rather interesting. This mutation seems to cause an increase in binding of sigma 70 to beta '. The large increase in relative binding seen in the far Western may not have been derived strictly from an increase in affinity of the mutant beta ' fragment for sigma 70. The beta ' fragment containing this mutation could be better suited than the wild type fragment to refold its native conformation while attached to the nitrocellulose. Therefore, a larger population of properly folded protein may exist to bind sigma 70. The increase in relative sigma 70 binding by the Q300E beta ' mutant in the far Western was not as dramatic in vivo possibly due to the sigma 70-core interaction having a larger Keq than the sigma 70-beta ' interaction. However, the assembly of Esigma 70 for this mutant was still almost twice that of wild type. Inhibitors based on coiled coil interactions have proven to be useful in disrupting such processes as viral entry into cells and topoisomerase activity (32-34). Our laboratory has begun work to design inhibitors of the sigma -core interaction for potential use as antibacterial therapeutics. The Q300E mutation may provide useful information on increasing the binding constant of such an inhibitor.

The alternative sigma  factors have been thought to bind to the same sites on core RNAP as sigma 70. Mutating conserved residues of different sigma  species will disrupt core binding (6). Traviglia et al. (7) used tethered Fe-EDTA cleavage to determine that several of the minor sigma  species of E. coli are in close proximity to the same regions of core RNAP as sigma 70 within the Esigma complex. We found that, at least for sigma 32 and sigma F, minor sigma  factors do bind one of the same sites on core as sigma 70. Although they are binding to the same site, there is some difference in the manner of binding. The Q300E mutation that increased binding of sigma 70 had the opposite effect, especially in stationary phase, on sigma 32 and sigma F. R297S also had different binding properties for the sigma  factors. This mutation caused an increased binding of the minor sigma s and reduced binding of sigma 70. It is interesting that these mutations both had opposite effects on sigma 70 and the minor sigma s, although only two minor sigma s were at detectable levels. This suggests that changes in the local environment could favor or hinder minor sigma  binding as a whole as compared with sigma 70. The patterns of binding to the various beta ' mutants need to be determined for more of the minor sigma s in order to substantiate this hypothesis.

Finally, the crystal structure of T. aquaticus core RNAP has been of great utility in trying to understand the results of the mutations. Based on the computer predictions and our mutational results, we could not have concluded that beta '260-309 formed a coiled coil structure. However, combining this information with the T. aquaticus versus E. coli beta ' sequence alignment and the T. aquaticus crystal structure, it is clear that beta '260-309 adopts a coiled coil conformation. Upon sigma  binding, though, it is not clear what structure this region takes on. Conserved region 2.1 of sigma 70, implicated in core binding (8), forms a coiled coil with region 1.2 in the crystal structure of the sigma 70 protease-resistant domain (35). Also, a predicted coiled coil in sigma 54 of E. coli has been found to be important in the sigma -core interaction (36). These sigma  factor structures may be interacting with beta '260-309 to form a four-helix coiled coil. It is also known that the sigma  factor undergoes a conformational change upon binding core (11, 37, 38). This may be caused by a rearrangement of the coiled coils to form new contacts (39, 40).

From the clustering of the group 1 mutations on the same face of the coiled coil structure and the positioning of the group 2 mutations on the edges of the cluster and the group 3 members on the opposite side of the coiled coil, we conclude that we have defined the binding interface for sigma 70 on beta '. Recent work in our laboratory has localized the region of sigma 70 that is interacting with beta '260-309 to a peptide containing a portion of the nonconserved region and region 2.1 of the sigma 70 subunit (41). beta ' region 198-237 was identified by Brodolin et al. (42) as interacting with the nontemplate strand of the lacUV5 promoter, which also is known to be contacted by region 2.4 of sigma 70 (43, 44). We are now in a position to model the sigma -core interaction using these results as landmarks.

    ACKNOWLEDGEMENTS

We are grateful to S. Darst for generously providing us with the T. aquaticus core RNAP structure coordinates. We thank K. Severinov for the T. aquaticus rpoC gene sequence and R. Landick for gifts of strain RL602 and plasmids. We also thank V. Svetlov and N. Thompson for technical advice and critical reading of the manuscript.

    FOOTNOTES

* This work was supported by National Institutes of Health Grant GM28575 (to R. R. B.) and by National Institutes of Health Biotechnology Training Grant Fellowship ST32GM08349 (to T. M. A.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, 1400 University Ave., Madison, WI 53706. Tel.: 608-263-2635; Fax: 608-262-2824; E-mail: burgess@oncology.wisc.edu.

Published, JBC Papers in Press, April 11, 2000, DOI 10.1074/jbc.M002040200

2 L. Minakhin and K. Severinov, personal communication.

    ABBREVIATIONS

The abbreviations used are: RNAP, RNA polymerase; Ni2+-NTA, nickel nitrilotriacetic acid; wt, wild type.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Helmann, J. D., and Chamberlin, M. J. (1988) Annu. Rev. Biochem. 57, 839-872
2. Burgess, R. R., Travers, A. A., Dunn, J. J., and Bautz, E. K. F. (1969) Nature 221, 43-46
3. Gross, C. A., Chan, C. L., and Lonetto, M. A. (1996) Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 351, 475-482
4. Gross, C. A., Lonetto, M., and Losick, R. (1992) in Transcriptional Regulation (McKnight, S. , and Yamamoto, K., eds) , pp. 129-176, Cold Spring Harbor Press, Cold Spring Harbor, NY
5. Lonetto, M., Gribskov, M., and Gross, C. A. (1992) J. Bacteriol. 174, 3843-3849
6. Sharp, M. M., Chan, C. L., Lu, C. Z., Marr, M. T., Nechaev, S., Merritt, E. W., Severinov, K., Roberts, J. W., and Gross, C. A. (1999) Genes Dev. 13, 3015-3026
7. Traviglia, S. L., Datwyler, S. A., Yan, D., Ishihama, A., and Meares, C. F. (1999) Biochemistry 38, 15774-15778
8. Lesley, S. A., and Burgess, R. R. (1989) Biochemistry 28, 7728-7734
9. Shuler, M. F., Tatti, K. M., Wade, K. H., and Moran, C. P., Jr. (1995) J. Bacteriol. 177, 3687-3694
10. Joo, D. M., Nolte, A., Calendar, R., Zhou, Y. N., and Jin, D. J. (1998) J. Bacteriol. 180, 1095-1102
11. Nagai, H., and Shimamoto, N. (1997) Genes Cells 2, 725-734
12. Owens, J. T., Miyake, R., Murakami, K., Chmura, A. J., Fujita, N., Ishihama, A., and Meares, C F. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 6021-6026
13. Fisher, R., and Blumenthal, T. (1980) J. Biol. Chem. 255, 11056-11062
14. Arthur, T. M., and Burgess, R. R. (1998) J. Biol. Chem. 273, 31381-31387
15. Rost, B., Sander, C., and Schneider, R. (1994) CABIOS 10, 53-60
16. Lupas, A., Van Dyke, M., and Stock, J. (1991) Science 252, 1162-1164
17. Cohen, C., and Parry, D. A. D. (1986) Trends Biochem. Sci. 11, 245-248
18. Chao, H., Bautista, D. L., Litowski, J., Irvin, R. T., and Hodges, R. S. (1998) J. Chromatogr. B Biomed. Sci. Appl. 715, 307-329
19. Zhang, G., Campbell, E. A., Minakhin, L., Richter, C., Severinov, K., and Darst, S. A. (1999) Cell 98, 811-824
20. Wang, D., Meier, T. I., Chan, C. L., Feng, G., Lee, D. N., and Landick, R. L. (1995) Cell 81, 341 350
21. Gribskov, M., and Burgess, R. R. (1986) Nucleic Acids Res. 14, 6745-6763
22. Weilbaecher, R., Hebron, C., Feng, G., and Landick, R. (1994) Genes Dev. 8, 2913-2917
23. Ridley, S. P., and Oeshger, M. P. (1982) J. Bacteriol. 152, 736-746
24. Thompson, N. E., Hager, D. A., and Burgess, R. R. (1992) Biochemistry 31, 7003-7008
25. Sayle, R. A., and Milner-White, E. J. (1995) Trends Biochem. Sci. 20, 374
26. Bogan, A. A., and Thorn, K. S. (1998) J. Mol. Biol. 280, 1-9
27. Jishage, M., Iwata, A., Ueda, S., and Ishihama, A. (1996) J. Bacteriol. 178, 5447-5451
28. Ju, J., Mitchell, T., Peters, H., III, and Haldenwang, W. G. (1999) J. Bacteriol. 181, 4969-4977
29. Farewell, A., Kvint, K., and Nystrom, T. (1998) Mol. Microbiol. 29, 1039-1051
30. Fujita, M. (2000) Genes Cells 5, 79-88
31. Muñoz, V., and Serrano, L. (1994) Nat. Struct. Biol. 1, 399-409
32. Eckert, D. M., Malashkevich, V. N., Hong, L. H., Carr, P. A., and Kim, P. S. (1999) Cell 99, 103-115
33. Wild, C. T., Shugars, D. C., Greenwell, T. K., McDanal, C. B., and Matthews, T. J. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 9770-9774
34. Frere-Gallois, V., Krebs, D., Scala, D., Troalen, F., and Fermandjian, S. (1997) Eur. J. Biochem 249, 142-148
35. Malhotra, A., Severinova, E., and Darst, S. A. (1996) Cell 87, 127-136
36. Hsieh, M., Hsu, H., Hwang, S., Wen, F., Yu, J., Wen, C., and Li, C. (1999) Microbiology 145, 3081-3088
37. Callaci, S., Heyduk, E., and Heyduk, T. (1998) J. Biol. Chem. 273, 32995-33001
38. McMahan, S. A., and Burgess, R. R. (1999) Biochemistry 38, 12424-12431
39. Grum, V. L., Li, D., MacDonald, R. I., and Mondragon, A. (1999) Cell 98, 523-535
40. El-Kettani, M. A., and Smith, J. C. (1996) C. R. Acad. Sci. III 319, 161-169
41. Burgess, R. R., Arthur, T. M., and Pietz, B. C. (1998) Cold Spring Harbor Symp. Quant. Biol. 63, 277-287
42. Brodolin, K., Mustaev, A., Severinov, K., and Nikiforov, V. (2000) J. Biol. Chem. 275, 3661-3666
43. Siegele, D. A., Hu, J. C., Walter, W. A., and Gross, C. A. (1989) J. Mol. Biol. 206, 591-603
44. Waldburger, C., Gardella, T., Wong, R., and Susskind, M. M. (1990) J. Mol. Biol. 215, 267-276
45. Jokerst, R. S., Weeks, J. R., Zehring, W. A., and Greenleaf, A. L. (1989) Mol. Gen. Genet. 215, 266 275


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Sevostyanova, V. Svetlov, D. G. Vassylyev, and I. Artsimovitch
The elongation factor RfaH and the initiation factor {sigma} bind to the same site on the transcription elongation complex
PNAS, January 22, 2008; 105(3): 865 - 870.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
J. V. McDowell, M. E. Harlin, E. A. Rogers, and R. T. Marconi
Putative Coiled-Coil Structural Elements of the BBA68 Protein of Lyme Disease Spirochetes Are Required for Formation of Its Factor H Binding Site
J. Bacteriol., February 15, 2005; 187(4): 1317 - 1323.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Berghofer-Hochheimer, C. Z. Lu, and C. A. Gross
Altering the interaction between {sigma}70 and RNA polymerase generates complexes with distinct transcription-elongation properties
PNAS, January 25, 2005; 102(4): 1157 - 1162.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
S. Mahren and V. Braun
The FecI Extracytoplasmic-Function Sigma Factor of Escherichia coli Interacts with the {beta}' Subunit of RNA Polymerase
J. Bacteriol., March 15, 2003; 185(6): 1796 - 1802.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
V. Bergendahl, T. Heyduk, and R. R. Burgess
Luminescence Resonance Energy Transfer-Based High-Throughput Screening Assay for Inhibitors of Essential Protein-Protein Interactions in Bacterial RNA Polymerase
Appl. Envir. Microbiol., March 1, 2003; 69(3): 1492 - 1498.
[Abstract] [Full Text] [PDF]